Lymphoma News and Research

RSS
Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.
Multiple, intertwined cell death systems to prevent the spread of 'intracellular' bacteria

Multiple, intertwined cell death systems to prevent the spread of 'intracellular' bacteria

Clinical study evaluates potential of oral cancer drug to reduce respiratory symptoms of COVID-19

Clinical study evaluates potential of oral cancer drug to reduce respiratory symptoms of COVID-19

Combination of certain drugs can do more harm than good, shows study

Combination of certain drugs can do more harm than good, shows study

FDA approves first CAR T-cell therapy for patients with mantle cell lymphoma

FDA approves first CAR T-cell therapy for patients with mantle cell lymphoma

Yale and AI Therapeutics launch clinical trial of potential COVID-19 drug

Yale and AI Therapeutics launch clinical trial of potential COVID-19 drug

AI Therapeutics announces start of Phase II clinical trial of potential COVID-19 treatment

AI Therapeutics announces start of Phase II clinical trial of potential COVID-19 treatment

First CAR T-cell therapy for mantle cell lymphoma receives FDA approval

First CAR T-cell therapy for mantle cell lymphoma receives FDA approval

Combining two immunotherapies into a single treatment found to be more effective

Combining two immunotherapies into a single treatment found to be more effective

Reactivation of divergent signaling pathways can be leveraged to enhance cancer treatment

Reactivation of divergent signaling pathways can be leveraged to enhance cancer treatment

Guidelines for making neutering decision

Guidelines for making neutering decision

Study identifies possible factors to predict severe toxicities in CAR T patients

Study identifies possible factors to predict severe toxicities in CAR T patients

Anaplastic large cell lymphoma: Defense mechanism against certain drugs promotes cancer growth

Anaplastic large cell lymphoma: Defense mechanism against certain drugs promotes cancer growth

Dual inhibitor therapy may be safer for CLL patients, Moffitt study shows

Dual inhibitor therapy may be safer for CLL patients, Moffitt study shows

New cancer vaccine shows promising signs in preclinical studies

New cancer vaccine shows promising signs in preclinical studies

Mapping immune landscape of hematological malignancies may help improve cancer therapies

Mapping immune landscape of hematological malignancies may help improve cancer therapies

Breast cancer simulation models can guide screening recommendations for women

Breast cancer simulation models can guide screening recommendations for women

Fertility can be successfully preserved in breast cancer patients, shows study

Fertility can be successfully preserved in breast cancer patients, shows study

New NCCN guidelines explain how to recognize and manage immunotherapy-related side effects

New NCCN guidelines explain how to recognize and manage immunotherapy-related side effects

Researchers receive innovative grants to understand the biological underpinnings of blood cancers

Researchers receive innovative grants to understand the biological underpinnings of blood cancers

Research shows how a protein's small change leads to big trouble for cells

Research shows how a protein's small change leads to big trouble for cells